suplatast tosilate has been researched along with toluene 2,4-diisocyanate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukui, H; Hattori, M; Horio, S; Kitamura, Y; Maeyama, K; Mizuguchi, H; Orimoto, N; Shahriar, M; Takeda, N; Umehara, H | 1 |
| Adachi, T; Das, AK; Fukui, H; Kadota, T; Kitamura, Y; Kominami, T; Kosaka, T; Matsumoto, M; Miyagi, K; Mizuguchi, H; Orimoto, N; Sawada, A; Takeda, N; Tamada, M | 1 |
2 other study(ies) available for suplatast tosilate and toluene 2,4-diisocyanate
| Article | Year |
|---|---|
Suplatast tosilate inhibits histamine signaling by direct and indirect down-regulation of histamine H1 receptor gene expression through suppression of histidine decarboxylase and IL-4 gene transcriptions.
Topics: Animals; Arylsulfonates; Down-Regulation; HeLa Cells; Histamine; Histidine Decarboxylase; Humans; Interleukin-4; Rats; Receptors, Histamine H1; RNA, Messenger; Signal Transduction; Sulfonium Compounds; Toluene 2,4-Diisocyanate; Transcription, Genetic | 2009 |
Suplatast tosilate alleviates nasal symptoms through the suppression of nuclear factor of activated T-cells-mediated IL-9 gene expression in toluene-2,4-diisocyanate-sensitized rats.
Topics: Animals; Anti-Allergic Agents; Arylsulfonates; Calcineurin; Cells, Cultured; Drug Therapy, Combination; Gene Expression; Histamine Antagonists; Hypersensitivity; Interleukin-9; Male; NFATC Transcription Factors; Nose Diseases; Rats; Receptors, Histamine H1; Signal Transduction; Sulfonium Compounds; Toluene 2,4-Diisocyanate | 2016 |